Title: Naurex's First Orally Active Molecule, NRX-1074, Demonstrates Statistically Significant Improvement in Depression Scores within 24 Hours in Phase 2 Study for Major Depressive Disorder. January 28, 2015.
178249-42-8
840-79-9
142155-24-6
24205-68-3
139026-66-7
157618-75-2
1155573-50-4 | 1-(2-Bromophenyl)-3,5-dimethylpyrazole | AA000G25 | MFCD12134495
130657-47-5 | (3Ar,4r,6as)-rel-octahydrocyclopenta[c]pyrrol-4-ol hydrochloride | AA000UOJ | MFCD28892967
1226808-66-7 | 4-(4-Ethoxycarbonyl)piperazino-1-bromobenzene | AA0017J8 | MFCD16295047
16111-27-6 | S-(2-Dimethylaminoethyl)isothiourea diHCl | AA001S3M | MFCD00060161
2055839-78-4 | 1-(2,6-Diazaspiro[3.3]heptan-2-yl)ethan-1-one trifluoroacetic acid | AA002A3F | MFCD30530451
30413-54-8 | 2-Ethynyl-4-methylpyridine | AA002ZZF | MFCD13175245
808-12-8 | 1,2-BIS(4-METHYLPHENYL)-1,2-DIPHENYL-1,2-ETHANEDIOL | AA003D9F | MFCD00026012
674783-97-2 | 9-Mesityl-10-methylacridinium Perchlorate | AA003NII | MFCD09038536
593-29-3 | Potassium stearate | AA003TUJ | MFCD00072385
80693-00-1 | Bis(2,6-di-ter-butyl-4-methylphenyl)pentaerythritol-diphosphite | AA005JUO | MFCD00513695